Parmax Pharma Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹1.34Cr |
Net Profits | ₹-1.75Cr |
Net Profit Margins | -130.60% |
Highlights
Revenue:
Parmax Pharma Ltd’s revenue fell -75% since last year same period to ₹1.34Cr in the Q3 2023-2024. On a quarterly growth basis, Parmax Pharma Ltd has generated -67.16% fall in its revenue since last 3-months.
Net Profits:
Parmax Pharma Ltd’s net profit fell -200.57% since last year same period to ₹-1.75Cr in the Q3 2023-2024. On a quarterly growth basis, Parmax Pharma Ltd has generated -27.74% fall in its net profits since last 3-months.
Net Profit Margins:
Parmax Pharma Ltd’s net profit margin fell -502.3% since last year same period to -130.60% in the Q3 2023-2024. On a quarterly growth basis, Parmax Pharma Ltd has generated -288.93% fall in its net profit margins since last 3-months.
